Phase 2 Trial of Pembrolizumab To Prevent Recurrence in Head and Neck Cancer - Cancer Therapy Advisor

Cancer Therapy Advisor

Phase 2 Trial of Pembrolizumab To Prevent Recurrence in Head and Neck Cancer Cancer Therapy Advisor Description: For this randomized, phase 2 study, researchers are evaluating whether intravenous pembrolizumab will improve progression-free survival (PFS) among patients with head and neck cancer at high risk of recurrence. All enrolled patients will ...

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2sYUAc5
via IFTTT